These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 2838924

  • 1. Low molecular weight heparin in haemodialysis for chronic renal failure: dose finding study of CY222.
    Ireland H, Lane DA, Flynn A, Pegrum AC, Curtis JR.
    Thromb Haemost; 1988 Apr 08; 59(2):240-7. PubMed ID: 2838924
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dose finding study of a low molecular weight heparin, Innohep, in haemodialysis.
    Ryan KE, Lane DA, Flynn A, Shepperd J, Ireland HA, Curtis JR.
    Thromb Haemost; 1991 Sep 02; 66(3):277-82. PubMed ID: 1745997
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin.
    Anastassiades E, Lane DA, Ireland H, Flynn A, Curtis JR.
    Clin Nephrol; 1989 Dec 02; 32(6):290-6. PubMed ID: 2558829
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Anticoagulation in hemodialysis sessions with a low molecular weight heparin (CY 222, Choay). Dosage studies in chronic hemodialysis. Its use in patients at high risk of hemorrhage].
    Dieval J, Morinière P, Roussel B, Bayrou B, Fournier A, Delobel J.
    J Mal Vasc; 1987 Dec 02; 12 Suppl B():114-8. PubMed ID: 2834482
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin.
    Cadroy Y, Harker LA, Hanson SR.
    J Lab Clin Med; 1989 Oct 02; 114(4):349-57. PubMed ID: 2551985
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Monitoring Unfractionated Heparin (UFH) therapy: which Anti-Factor Xa assay is appropriate?
    Ignjatovic V, Summerhayes R, Gan A, Than J, Chan A, Cochrane A, Bennett M, Horton S, Shann F, Lane G, Ross-Smith M, Monagle P.
    Thromb Res; 2007 Oct 02; 120(3):347-51. PubMed ID: 17118432
    [Abstract] [Full Text] [Related]

  • 12. The anticoagulant effect of heparinoid Org 10172 during haemodialysis: an objective assessment.
    Ireland H, Lane DA, Flynn A, Anastassiades E, Curtis JR.
    Thromb Haemost; 1986 Apr 30; 55(2):271-5. PubMed ID: 3715791
    [Abstract] [Full Text] [Related]

  • 13. Effects of a low molecular weight heparin (Fragmin) and of unfractionated heparin on coagulation activation at the site of plug formation in vivo.
    Eichinger S, Wolz M, Nieszpaur-Los M, Schneider B, Lechner K, Eichler HG, Kyrle PA.
    Thromb Haemost; 1994 Dec 30; 72(6):831-5. PubMed ID: 7740450
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A single dose of a low molecular weight heparin fragment for anticoagulation during hemodialysis.
    Ljungberg B, Blombäck M, Johnsson H, Lins LE.
    Clin Nephrol; 1987 Jan 30; 27(1):31-5. PubMed ID: 3815906
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.